A long-term analysis of yttrium 90 (Y90) radioembolization for patients with advanced stage hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) shows that Y90 is safe and effective. Researchers analyzed data from a subset of 1,000 consecutive patients with HCC who were treated with… Read More
HCC cells
Margins greater than 5 mm are necessary for local tumor control for both radiofrequency ablation and percutaneous microwave ablation, researchers reported in the Journal of Vascular and Interventional Radiology. Researchers conducted a retrospective review to determine which factors may predict… Read More
Dynamic CT studies are a typical part of the preoperative evaluation of the hypervascularity of hepatocellular carcinoma (HCC), but certain patients may benefit from the addition of computed tomography during hepatic arteriography (CTHA). Researchers reported their findings in Cardiovascular and… Read More
Patients who underwent radiation segmentectomy had better responses on imaging and greater time to secondary therapy (TTST) than patients who received transarterial chemoembolization (TACE) for treatment of early-stage hepatocellular carcinoma (HCC). Radiation segmentectomy involves giving lobar… Read More
Patients who have recurrent hepatocellular carcinoma (HCC) following resection may benefit from radioembolization, which is safe and effective in those circumstances, researchers reported. When HCC recurs, patients who have already undergone resection often have limited hepatic reserve, making… Read More
patient consultation
Most patients prefer transradial access when undergoing intra-arterial therapy for liver cancer, according to a study published in JVIR. A comparison of transradial and transfemoral access showed that the number of adverse events, as well as the procedure time, contrast agent volume, and patient… Read More
Local control of adrenal gland metastases that measure < 5 cm can be accomplished through the use of image-guided ablation, according to a study published in the Journal of Vascular and Interventional Radiology. Less invasive treatments for adrenal metastases are needed because patient… Read More
Patients with localized T1a clear cell renal cell carcinoma (ccRCC) had better survival outcomes when they were treated with local ablative techniques instead of deferring surgical therapy, according to a study published in the Journal of Cardiovascular and Interventional Radiology. Although… Read More
A new study suggests that drug-eluting embolic agent (DEE) transarterial chemoembolization is both safe and has a significantly greater cytoreductive effect than transarterial embolization (TAE) for treating localized renal cell carcinoma (RCC). In a prospective, randomized trial that took place… Read More
HCC cells
Radiofrequency ablation plus transcatheter arterial chemoembolization (TACE) may yield similar overall survival (OS) rates to liver resection in patients with cirrhosis and large, solitary hepatocellular carcinoma (HCC) tumors, researchers reported. Liver resection remains the standard-of-care for… Read More